Capital Region Southwest Campus — Jefferson City, Missouri

Capital Region Southwest Campus is a clinical research site located in Jefferson City, Missouri, United States 65109.

Crixeo Clinical Trials Trust Score: 29/100 (FAILING). This profile has not yet been claimed by the site owner.

Capital Region Southwest Campus has participated in 87 clinical trials with 35 currently active.

Therapeutic areas: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma.

Sponsors: National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jefferson City

Browse all research sites in Missouri · View every site in Jefferson City

• SSM Health St. Mary's Hospital - Jefferson City
• Capital Region Hospital
• MU Health Care Goldschmidt Cancer Center
• Capital Region Medical Center-Goldschmidt Cancer Center
• Jefferson City Medical Group
• Goldschmidt Cancer Center
• Novo Nordisk Investigational Site
• GSK Investigational Site
• Pfizer Investigational Site
• Research Site
• Capitol Comprehensive Cancer Care Clinic

Sponsor Feasibility Report

Trust Score: 29/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Region Southwest Campus?

Capital Region Southwest Campus has a Crixeo Trust Score of 29/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Region Southwest Campus conducted?

Capital Region Southwest Campus has 87 clinical trials on record, with 35 currently active. Their work covers Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma.

Is Capital Region Southwest Campus accredited by Crixeo Clinical Trials?

Capital Region Southwest Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Capital Region Southwest Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.